TYTatiana Yakovleva

Tatiana Yakovleva

*This is an algorithmically generated author record based on publicly available information.

Tatiana Yakovleva has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Main results and directions for imptoving seafarers’ medical care in system of Federal medical biological agency of Russian Federation: retrospective study

    by Tatyana V. Yakovleva, Olga Yu. Turenko, Vyacheslav A. Ratnikov, Svetlana S. Moskaleva, Татьяна Владимировна Яковлева, Ольга Юрьевна Туренко, Вячеслав Альбертович Ратников, Светлана Сергеевна Москалева

    OBJECTIVE . Determine the main results and directions for improving the system of seafarers’ medical care, optimize the organizational and staff structure of institutions of the Russia’s Federal Medical and Biological Agency (FMBA) to ensure an optimal interaction in the process of implementing tasks, faced by this organization. MATERIALS AND METHODS. There was a systematic analysis of organizational work principles of organizations for the period 2014–2021, providing medical care to seafarers and included in the structure of the Russia’s FMBA, and data on the morbidity of seafarers and divers for 2023 were obtained and systematized. The work analysis on medical assistance of persons, employed in vessels, was performed as of June 1 st , 2024 and on the results of activities of 35 health centres, 70 physicians on shipboard, 14 doctors of diving medicine in the structure of the Russian’s FMBA. RESULTS . For efficient medical assistance of seafarers, coordination of interaction between the specialized department of the Russia’s FMBA and subordinated institutions of the Agency, the head centre of seafarers’ healthcare has been established. The data has been systematized on overall morbidity of seafarers and divers, as well as on newly diagnosed diseases for 2023. DISCUSSION . Improvement of healthcare management for persons, employed on vessels in the system of Russia’s FMBA, as well as information and analytical healthcare provision for seafarers will be continued. The specified activity is essential for systematizing full information on seafarers, its analysis and the creation of new directions in service development, which corresponds to the requirements of the new Maritime Doctrine of the Russian Federation. CONCLUSION . As a result of this work the main action lines are identified for improving scientific approaches to the organization and development of marine and diving medicine in the Russian Federation.

  • Open Access

    A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes

    by Victor Sokolov, Tatiana Yakovleva, Leonid Stolbov, Robert C. Penland, David Boulton, Joanna Parkinson, Weifeng Tang

    Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by abnormally high blood glucose concentrations due to dysfunction of the insulin‐producing beta‐cells in the pancreas. Dapagliflozin, an inhibitor of renal glucose reabsorption, has the potential to improve often suboptimal glycemic control in patients with T1DM through insulin‐independent mechanisms and to partially mitigate the adverse effects associated with long‐term insulin administration. In this work, we have adapted a systems pharmacology model of type 2 diabetes mellitus to describe the T1DM condition and characterize the effect of dapagliflozin on short‐ and long‐term glycemic markers under various treatment scenarios. The developed platform serves as a quantitative tool for the in silico evaluation of the insulin‐glucose‐dapagliflozin crosstalk, optimization of the treatment regimens, and it can be further expanded to include additional therapies or other aspects of the disease.


  • A model‐based approach to investigating the relationship between glucose‐insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes

    by Millie Shah, Leonid Stolbov, Tatiana Yakovleva, Weifeng Tang, Victor Sokolov, Robert C. Penland, David Boulton, Joanna Parkinson

    Aims: To develop a quantitative systems pharmacology model to describe the effect of dapagliflozin (a sodium‐glucose co‐transporter‐2 [SGLT2] inhibitor) on glucose‐insulin dynamics in type 2 diabetes mellitus (T2DM) patients, and to identify key determinants of treatment‐mediated glycated haemoglobin (HbA1c) reduction. Materials and methods: Glycaemic control during dapagliflozin treatment was mechanistically characterized by integrating components representing dapagliflozin pharmacokinetics (PK), glucose‐insulin homeostasis, renal glucose reabsorption, and HbA1c formation. The model was developed using PK variables, glucose, plasma insulin, and urinary glucose excretion (UGE) from a phase IIa dapagliflozin trial in patients with T2DM (NCT00162305). The model was used to predict dapagliflozin‐induced HbA1c reduction; model predictions were compared to actual data from phase III trials (NCT00528879, NCT00683878, NCT00680745 and NCT00673231). Results: The integrated glucose‐insulin‐dapagliflozin model successfully described plasma glucose and insulin levels, as well as UGE in response to oral glucose tolerance tests and meal intake. HbA1c reduction was also well predicted. The results show that dapagliflozin‐mediated glycaemic control is anticorrelated to steady‐state insulin concentration and insulin sensitivity. Conclusions: The developed model framework is the first to integrate SGLT2 inhibitor mechanism of action with both short‐term glucose‐insulin dynamics and long‐term glucose control (HbA1c). The results suggest that dapagliflozin treatment is beneficial in patients with inadequate glycaemic control from insulin alone and this benefit increases as insulin control diminishes.


  • Open Access

    ORGANIZATIONAL AND PEDAGOGICAL CONDITIONS FOR SECONDARY SCHOOL TO JOIN THE MEGA-CLASS NETWORK PROJECT OF THE EDUCATIONAL CLUSTER PLATFORM

    by L.V. Popova, T.A. Yakovleva, Kspu Named After V.P. Astafiev

    Проблема и цель. Актуальность проблемы организации учебной деятельности школы в образовательных кластерах связана с отсутствием нормативно-правовой и учебно-методической базы участия в сетевых проектах. Необходимость вхождения становится очевидной с появлением концепции преподавания предметной области «Технология» в образовательных организациях Российской Федерации, национальной технологической инициативы. Цель работы – обоснование и представление организационно-педагогических условий вхождения школы в сетевой проект образовательной кластерной технологической платформы «Мега-класс» для формирования инженерно-технологических компетенций школьников. Методологию исследования составляют анализ литературы, посвященной опыту организации учебного процесса в образовательных кластерах; анализ основных направлений развития основного общего и дополнительного образования, заложенных в Национальной технологической инициативе; анализ Концепции преподавания предметной области «Технология» в образовательных организациях Российской Федерации, реализующих основные общеобразовательные программы; анализ Концепции кластерной технологической платформы «Мегакласс». Результаты. На основании анализа проблем экспериментального участия лицея № 1 в сетевых проектах на кластерной технологической платформе «Мега-класс» обоснованы и описаны организационные и педагогические условия успешного вхождения школы в сетевой образовательный кластер, реализующий кооперацию общеобразовательной школы, вуза и бизнеса. Заключение. Разработанная модель позволит создать в образовательном учреждении инновационную образовательную среду для повышения качества обучения школьников и квалификации педагогических работников в контексте Концепции технологического образования и Национальной технологической инициативы. Материалы статьи представляют интерес для администрации и учителей школ, желающих участвовать в сетевых образовательных проектах.

  • Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors

    by Tatiana Yakovleva, Victor Sokolov, Lulu Chu, Weifeng Tang, Peter J. Greasley, Helena Peilot Sjögren, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W. Boulton, et al.

    Aim Sodium glucose cotransporter 2 inhibitors (SGLT2i) are a class of oral glucose lowering compounds used to treat type 2 diabetes mellitus (T2DM). Paradoxically, SGLT2 is responsible for over 80% of proximal tubule glucose reabsorption in SGLT2i naïve T2DM patients, yet SGLT2i treatment results in only 30‐50% less reabsorption. We propose a mechanistic explanation of these observations using a quantitative drug‐disease systems model. Materials and methods A physiologically based four‐compartment model of renal glucose filtration, reabsorption, and excretion via SGLT1 and SGLT2 was developed as a system of ordinary differential equations using R/IQRtools. SGLT2i pharmacokinetics and pharmacodynamics were estimated from published concentration‐time profiles in plasma and urine and from urinary glucose excretion (UGE) in healthy and T2DM subjects. Results The final model shows that higher renal glucose reabsorption in T2DM patients vs. healthy subjects is associated with 54% and 28% greater Vmax for SGLT1 and SGLT2, respectively. Additionally, the analysis showed that UGE is highly dependent on mean plasma glucose (MPG) and estimated glomerular filtration rate (eGFR) and that their consideration is critical for interpreting clinical UGE findings. Conclusions Quantitative drug‐disease systems modelling revealed mechanistic differences in renal glucose reabsorption and UGE between healthy and T2DM patients and clearly showed that SGLT2 inhibition significantly increased glucose available to SGLT1 downstream in the tubule. Importantly, we found that the less than expected UGE findings with SGLT2 inhibition are explained by the shift to SGLT1 which recovered additional glucose (~30% of total).


  • Open Access

    Evaluation of compliance costs interrelation with a level of innovative economic development

    by Marina Ivanova, Olga Garmasar, Tatiana Yakovleva, Elena Glyass

    Theoretical and methodical provisions of compliance costs influence on the level of economy innovativeness are systematized in this article. The concept of compliance costs in the world literature is investigated, their role in the state regulation quality assurance is determined. Methods of correlation-regression analysis are used to evaluate interconnection of compliance costs in the sphere of tax payment and a number of indicators of social-economical system innovative development. The correlation analysis of interconnection between other components of standard costs was carried out (in particular, aggregate tax burden) in order to establish the influence of different elements of standard costs on the innovation indicators. The analysis has allowed making a conclusion on the absence of significant interconnection of compliance costs and the indicators being studied with simultaneous revelation of noticeable connection with a change in tax burden. The conclusion was made on a greater significance of financial component in the composition of standard costs as compared to the compliance costs.


  • Open Access

    Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus

    by Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W. Boulton, Robert C. Penland, Weifeng Tang

    Aims: To assess the dapagliflozin exposure‐response relationship in Japanese and non‐Japanese patients with type 1 diabetes mellitus (T1DM) and investigate if a dose adjustment is required in Japanese patients. Materials and Methods: Data from two clinical studies were used to develop a non‐linear mixed effects model describing the relationship between dapagliflozin exposure (area under the concentration curve) and response (24‐hour urinary glucose excretion [UGE]) in Japanese and non‐Japanese patients with T1DM. The effects of patient‐level characteristics (covariates; identified using a stepwise procedure) on response was also assessed. Simulations were performed using median‐normalized covariate values. Results: Data from 84 patients were included. Average self‐monitored blood glucose (SMBG) at day 7, change from baseline in total insulin dose at day 7, and baseline estimated glomerular filtration rate (eGFR) all had a significant effect on 24‐hours UGE, with SMBG being the most influential. Dapagliflozin systemic exposure for matching doses and baseline eGFR was similar between Japanese and non‐Japanese patients; however, higher SMBG and a greater reduction in total insulin dose was observed in the Japanese population. When the significant covariates were included, the model fit the data well for both populations, and accurately predicted exposure‐response in the Japanese and non‐Japanese populations, in agreement with the observed data. Conclusions: There was no difference in dapagliflozin exposure‐response in Japanese and non‐Japanese patients with T1DM once differences in renal function, glycaemic control and insulin dose reductions between studies were considered. Therefore, no dose adjustment is recommended in Japanese patients with T1DM.